Works matching IS 20590105 AND DT 2022 AND VI 7 AND IP 1
Results: 182
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00575-w
- By:
- Publication type:
- Article
Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00574-x
- By:
- Publication type:
- Article
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00577-8
- By:
- Publication type:
- Article
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00558-x
- By:
- Publication type:
- Article
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00572-z
- By:
- Publication type:
- Article
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00586-7
- By:
- Publication type:
- Article
Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00596-5
- By:
- Publication type:
- Article
ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00592-9
- By:
- Publication type:
- Article
Challenges and developments in universal vaccine design against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00597-4
- By:
- Publication type:
- Article
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00595-6
- By:
- Publication type:
- Article
RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00591-w
- By:
- Publication type:
- Article
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00580-z
- By:
- Publication type:
- Article
Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00588-5
- By:
- Publication type:
- Article
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00590-x
- By:
- Publication type:
- Article
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00589-4
- By:
- Publication type:
- Article
A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00585-8
- By:
- Publication type:
- Article
Serum antibody profiling identifies vaccine-induced correlates of protection against aerosolized ricin toxin in rhesus macaques.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. N.PAG, doi. 10.1038/s41541-022-00582-x
- By:
- Publication type:
- Article
Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00594-7
- By:
- Publication type:
- Article
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00590-x
- By:
- Publication type:
- Article
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00583-w
- By:
- Publication type:
- Article
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00587-6
- By:
- Publication type:
- Article
Rational development of a combined mRNA vaccine against COVID-19 and influenza.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00478-w
- By:
- Publication type:
- Article
Assembly-defective Tembusu virus ectopically expressing capsid protein is an approach for live-attenuated flavivirus vaccine development.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00468-y
- By:
- Publication type:
- Article
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00564-z
- By:
- Publication type:
- Article
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00573-y
- By:
- Publication type:
- Article
Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00545-2
- By:
- Publication type:
- Article
Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00576-9
- By:
- Publication type:
- Article
Author Correction: Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00570-1
- By:
- Publication type:
- Article
Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00568-9
- By:
- Publication type:
- Article
Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00567-w
- By:
- Publication type:
- Article
Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00566-x
- By:
- Publication type:
- Article
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00565-y
- By:
- Publication type:
- Article
Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infections.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00562-1
- By:
- Publication type:
- Article
Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00569-8
- By:
- Publication type:
- Article
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00561-2
- By:
- Publication type:
- Article
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00554-1
- By:
- Publication type:
- Article
Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00538-1
- By:
- Publication type:
- Article
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00558-x
- By:
- Publication type:
- Article
Yellow fever resurgence: An avoidable crisis?
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00552-3
- By:
- Publication type:
- Article
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00549-y
- By:
- Publication type:
- Article
DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00548-z
- By:
- Publication type:
- Article
TAFA4-IL-10 axis potentiate immunotherapy for airway allergy by induction of specific regulatory T cells.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00559-w
- By:
- Publication type:
- Article
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00557-y
- By:
- Publication type:
- Article
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00537-2
- By:
- Publication type:
- Article
Toxoplasmosis vaccines: what we have and where to go?
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00563-0
- By:
- Publication type:
- Article
B cells oppose Mycoplasmapneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00556-z
- By:
- Publication type:
- Article
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00560-3
- By:
- Publication type:
- Article
Immune correlates of protection following Rift Valley fever virus vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00551-4
- By:
- Publication type:
- Article